#aav vectors — Thursday, March 26, 2026 (1 items)
| 0 | ℹ |
AAV9 Gene Therapy in Type II GM1 Gangliosidosis - A Phase 1-2 Trial.
(nejm.org)
|
New England Journal of Medicine 2026-03-26 | #clinical trial #neurodegeneration #gene therapy #lysosomal storage disease #aav vectors |